Zip code

Condition


Search Radius:25 Miles
  • 5
  • 10
  • 15
  • 20
  • 25
  • 30
  • 40
  • 50
  • 100
  • 500
  • All

We've found
184,457
clinical trials

Lymphoma, Non-Hodgkin Clinical Trial
Lenalidomide Plus Rituximab Followed by Lenalidomide Versus Rituximab Maintenance for Relapsed/Refractory Follicular, Marginal Zone or Mantle Cell Lymphoma.
Status: Enrolling, Phase III
Updated: 12/31/1969
Texas Oncology, P.A. -Amarillo
mi
from
Amarillo, TX
Click here to add this to my saved trials
Lymphoma, Non-Hodgkin Clinical Trial
Lenalidomide Plus Rituximab Followed by Lenalidomide Versus Rituximab Maintenance for Relapsed/Refractory Follicular, Marginal Zone or Mantle Cell Lymphoma.
Status: Enrolling, Phase III
Updated: 12/31/1969
Sutter East Bay Hospitals
mi
from
Berkeley, CA
Click here to add this to my saved trials
Lymphoma, Non-Hodgkin Clinical Trial
Lenalidomide Plus Rituximab Followed by Lenalidomide Versus Rituximab Maintenance for Relapsed/Refractory Follicular, Marginal Zone or Mantle Cell Lymphoma.
Status: Enrolling, Phase III
Updated: 12/31/1969
Aultman Hospital
mi
from
Canton, OH
Click here to add this to my saved trials
Lymphoma, Non-Hodgkin Clinical Trial
Lenalidomide Plus Rituximab Followed by Lenalidomide Versus Rituximab Maintenance for Relapsed/Refractory Follicular, Marginal Zone or Mantle Cell Lymphoma.
Status: Enrolling, Phase III
Updated: 12/31/1969
Texas Oncology, PA
mi
from
Dallas, TX
Click here to add this to my saved trials
Lymphoma, Non-Hodgkin Clinical Trial
Lenalidomide Plus Rituximab Followed by Lenalidomide Versus Rituximab Maintenance for Relapsed/Refractory Follicular, Marginal Zone or Mantle Cell Lymphoma.
Status: Enrolling, Phase III
Updated: 12/31/1969
Alexian Brothers Hospital Network
mi
from
Elk Grove Village, IL
Click here to add this to my saved trials
Lymphoma, Non-Hodgkin Clinical Trial
Lenalidomide Plus Rituximab Followed by Lenalidomide Versus Rituximab Maintenance for Relapsed/Refractory Follicular, Marginal Zone or Mantle Cell Lymphoma.
Status: Enrolling, Phase III
Updated: 12/31/1969
Southeast Nebraska Cancer Center
mi
from
Lincoln, NE
Click here to add this to my saved trials
Lymphoma, Non-Hodgkin Clinical Trial
Lenalidomide Plus Rituximab Followed by Lenalidomide Versus Rituximab Maintenance for Relapsed/Refractory Follicular, Marginal Zone or Mantle Cell Lymphoma.
Status: Enrolling, Phase III
Updated: 12/31/1969
Hematology Oncology Associates
mi
from
Medford, OR
Click here to add this to my saved trials
Lymphoma, Non-Hodgkin Clinical Trial
Lenalidomide Plus Rituximab Followed by Lenalidomide Versus Rituximab Maintenance for Relapsed/Refractory Follicular, Marginal Zone or Mantle Cell Lymphoma.
Status: Enrolling, Phase III
Updated: 12/31/1969
Baptist Cancer Center
mi
from
Memphis, TN
Click here to add this to my saved trials
Lymphoma, Non-Hodgkin Clinical Trial
Lenalidomide Plus Rituximab Followed by Lenalidomide Versus Rituximab Maintenance for Relapsed/Refractory Follicular, Marginal Zone or Mantle Cell Lymphoma.
Status: Enrolling, Phase III
Updated: 12/31/1969
West Virginia University, Berkeley Medical Center, Cancer and Infusion Center
mi
from
Morgantown, WV
Click here to add this to my saved trials
Lymphoma, Non-Hodgkin Clinical Trial
Lenalidomide Plus Rituximab Followed by Lenalidomide Versus Rituximab Maintenance for Relapsed/Refractory Follicular, Marginal Zone or Mantle Cell Lymphoma.
Status: Enrolling, Phase III
Updated: 12/31/1969
Saint Peter's University Hospital
mi
from
New Brunswick, NJ
Click here to add this to my saved trials
Lymphoma, Non-Hodgkin Clinical Trial
Lenalidomide Plus Rituximab Followed by Lenalidomide Versus Rituximab Maintenance for Relapsed/Refractory Follicular, Marginal Zone or Mantle Cell Lymphoma.
Status: Enrolling, Phase III
Updated: 12/31/1969
Florida Cancer Affiliates
mi
from
New Port Richey, FL
Click here to add this to my saved trials
Lymphoma, Non-Hodgkin Clinical Trial
Lenalidomide Plus Rituximab Followed by Lenalidomide Versus Rituximab Maintenance for Relapsed/Refractory Follicular, Marginal Zone or Mantle Cell Lymphoma.
Status: Enrolling, Phase III
Updated: 12/31/1969
Virginia Oncology Associates
mi
from
Norfolk, VA
Click here to add this to my saved trials
Lymphoma, Non-Hodgkin Clinical Trial
Lenalidomide Plus Rituximab Followed by Lenalidomide Versus Rituximab Maintenance for Relapsed/Refractory Follicular, Marginal Zone or Mantle Cell Lymphoma.
Status: Enrolling, Phase III
Updated: 12/31/1969
The Board of Regents of the University of Oklahoma
mi
from
Oklahoma City, OK
Click here to add this to my saved trials
Lymphoma, Non-Hodgkin Clinical Trial
Lenalidomide Plus Rituximab Followed by Lenalidomide Versus Rituximab Maintenance for Relapsed/Refractory Follicular, Marginal Zone or Mantle Cell Lymphoma.
Status: Enrolling, Phase III
Updated: 12/31/1969
Vista Oncology, Inc.
mi
from
Olympia, WA
Click here to add this to my saved trials
Lymphoma, Non-Hodgkin Clinical Trial
Lenalidomide Plus Rituximab Followed by Lenalidomide Versus Rituximab Maintenance for Relapsed/Refractory Follicular, Marginal Zone or Mantle Cell Lymphoma.
Status: Enrolling, Phase III
Updated: 12/31/1969
Saint Louis University Cancer Center
mi
from
Saint Louis, MO
Click here to add this to my saved trials
Lymphoma, Non-Hodgkin Clinical Trial
Lenalidomide Plus Rituximab Followed by Lenalidomide Versus Rituximab Maintenance for Relapsed/Refractory Follicular, Marginal Zone or Mantle Cell Lymphoma.
Status: Enrolling, Phase III
Updated: 12/31/1969
Northwest Cancer Specialists
mi
from
Vancouver, WA
Click here to add this to my saved trials
Lymphoma, Non-Hodgkin Clinical Trial
Lenalidomide Plus Rituximab Followed by Lenalidomide Versus Rituximab Maintenance for Relapsed/Refractory Follicular, Marginal Zone or Mantle Cell Lymphoma.
Status: Enrolling, Phase III
Updated: 12/31/1969
Providence St. Mary Regional Cancer Center
mi
from
Walla Walla, WA
Click here to add this to my saved trials
Lymphoma, Non-Hodgkin Clinical Trial
Lenalidomide Plus Rituximab Followed by Lenalidomide Versus Rituximab Maintenance for Relapsed/Refractory Follicular, Marginal Zone or Mantle Cell Lymphoma.
Status: Enrolling, Phase III
Updated: 12/31/1969
Waukesha Memorial Hospital
mi
from
Waukesha, WI
Click here to add this to my saved trials
Multiple Myeloma in Relapse Clinical Trial
Pomalidomide and Dexamethasone With or Without Ixazomib in Treating Patients With Relapsed Multiple Myeloma
Status: Enrolling, Phase I, II
Updated: 12/31/1969
Lehigh Valley Hospital - Muhlenberg
mi
from
Bethlehem, PA
Click here to add this to my saved trials
Multiple Myeloma in Relapse Clinical Trial
Pomalidomide and Dexamethasone With or Without Ixazomib in Treating Patients With Relapsed Multiple Myeloma
Status: Enrolling, Phase I, II
Updated: 12/31/1969
Pacific Gynecology Specialists
mi
from
Seattle, WA
Click here to add this to my saved trials
Multiple Myeloma in Relapse Clinical Trial
Pomalidomide and Dexamethasone With or Without Ixazomib in Treating Patients With Relapsed Multiple Myeloma
Status: Enrolling, Phase I, II
Updated: 12/31/1969
Lehigh Valley Hospital-Cedar Crest
mi
from
Allentown, PA
Click here to add this to my saved trials
Multiple Myeloma in Relapse Clinical Trial
Pomalidomide and Dexamethasone With or Without Ixazomib in Treating Patients With Relapsed Multiple Myeloma
Status: Enrolling, Phase I, II
Updated: 12/31/1969
Providence Alaska Medical Center
mi
from
Anchorage, AK
Click here to add this to my saved trials
Multiple Myeloma in Relapse Clinical Trial
Pomalidomide and Dexamethasone With or Without Ixazomib in Treating Patients With Relapsed Multiple Myeloma
Status: Enrolling, Phase I, II
Updated: 12/31/1969
Rush - Copley Medical Center
mi
from
Aurora, IL
Click here to add this to my saved trials
Multiple Myeloma in Relapse Clinical Trial
Pomalidomide and Dexamethasone With or Without Ixazomib in Treating Patients With Relapsed Multiple Myeloma
Status: Enrolling, Phase I, II
Updated: 12/31/1969
Illinois CancerCare-Bloomington
mi
from
Bloomington, IL
Click here to add this to my saved trials
Multiple Myeloma in Relapse Clinical Trial
Pomalidomide and Dexamethasone With or Without Ixazomib in Treating Patients With Relapsed Multiple Myeloma
Status: Enrolling, Phase I, II
Updated: 12/31/1969
Saint Luke's Mountain States Tumor Institute
mi
from
Boise, ID
Click here to add this to my saved trials
Multiple Myeloma in Relapse Clinical Trial
Pomalidomide and Dexamethasone With or Without Ixazomib in Treating Patients With Relapsed Multiple Myeloma
Status: Enrolling, Phase I, II
Updated: 12/31/1969
Bozeman Deaconess Hospital
mi
from
Bozeman, MT
Click here to add this to my saved trials
Multiple Myeloma in Relapse Clinical Trial
Pomalidomide and Dexamethasone With or Without Ixazomib in Treating Patients With Relapsed Multiple Myeloma
Status: Enrolling, Phase I, II
Updated: 12/31/1969
Saint Francis Medical Center
mi
from
Cape Girardeau, MO
Click here to add this to my saved trials
Multiple Myeloma in Relapse Clinical Trial
Pomalidomide and Dexamethasone With or Without Ixazomib in Treating Patients With Relapsed Multiple Myeloma
Status: Enrolling, Phase I, II
Updated: 12/31/1969
Providence Oncology and Hematology Care Southeast
mi
from
Clackamas, OR
Click here to add this to my saved trials
Multiple Myeloma in Relapse Clinical Trial
Pomalidomide and Dexamethasone With or Without Ixazomib in Treating Patients With Relapsed Multiple Myeloma
Status: Enrolling, Phase I, II
Updated: 12/31/1969
Clackamas Radiation Oncology Center
mi
from
Clackamas, OR
Click here to add this to my saved trials
Multiple Myeloma in Relapse Clinical Trial
Pomalidomide and Dexamethasone With or Without Ixazomib in Treating Patients With Relapsed Multiple Myeloma
Status: Enrolling, Phase I, II
Updated: 12/31/1969
Mount Carmel Health Center West
mi
from
Columbus, OH
Click here to add this to my saved trials
Multiple Myeloma in Relapse Clinical Trial
Pomalidomide and Dexamethasone With or Without Ixazomib in Treating Patients With Relapsed Multiple Myeloma
Status: Enrolling, Phase I, II
Updated: 12/31/1969
Riverside Methodist Hospital
mi
from
Columbus, OH
Click here to add this to my saved trials
Multiple Myeloma in Relapse Clinical Trial
Pomalidomide and Dexamethasone With or Without Ixazomib in Treating Patients With Relapsed Multiple Myeloma
Status: Enrolling, Phase I, II
Updated: 12/31/1969
Cancer Center of Kansas, PA - Dodge City
mi
from
Dodge City, KS
Click here to add this to my saved trials
Multiple Myeloma in Relapse Clinical Trial
Pomalidomide and Dexamethasone With or Without Ixazomib in Treating Patients With Relapsed Multiple Myeloma
Status: Enrolling, Phase I, II
Updated: 12/31/1969
Pocono Medical Center
mi
from
East Stroudsburg, PA
Click here to add this to my saved trials
Multiple Myeloma in Relapse Clinical Trial
Pomalidomide and Dexamethasone With or Without Ixazomib in Treating Patients With Relapsed Multiple Myeloma
Status: Enrolling, Phase I, II
Updated: 12/31/1969
Carle Physician Group-Effingham
mi
from
Effingham, IL
Click here to add this to my saved trials
Multiple Myeloma in Relapse Clinical Trial
Pomalidomide and Dexamethasone With or Without Ixazomib in Treating Patients With Relapsed Multiple Myeloma
Status: Enrolling, Phase I, II
Updated: 12/31/1969
Illinois CancerCare - Galesburg
mi
from
Galesburg, IL
Click here to add this to my saved trials
Multiple Myeloma in Relapse Clinical Trial
Pomalidomide and Dexamethasone With or Without Ixazomib in Treating Patients With Relapsed Multiple Myeloma
Status: Enrolling, Phase I, II
Updated: 12/31/1969
NorthShore University HealthSystem-Glenbrook Hospital
mi
from
Glenview, IL
Click here to add this to my saved trials
Multiple Myeloma in Relapse Clinical Trial
Pomalidomide and Dexamethasone With or Without Ixazomib in Treating Patients With Relapsed Multiple Myeloma
Status: Enrolling, Phase I, II
Updated: 12/31/1969
Great Falls Clinic
mi
from
Great Falls, MT
Click here to add this to my saved trials
Multiple Myeloma in Relapse Clinical Trial
Pomalidomide and Dexamethasone With or Without Ixazomib in Treating Patients With Relapsed Multiple Myeloma
Status: Enrolling, Phase I, II
Updated: 12/31/1969
Green Bay Oncology at Saint Vincent Hospital
mi
from
Green Bay, WI
Click here to add this to my saved trials
Multiple Myeloma in Relapse Clinical Trial
Pomalidomide and Dexamethasone With or Without Ixazomib in Treating Patients With Relapsed Multiple Myeloma
Status: Enrolling, Phase I, II
Updated: 12/31/1969
Borgess Medical Center
mi
from
Kalamazoo, MI
Click here to add this to my saved trials
Multiple Myeloma in Relapse Clinical Trial
Pomalidomide and Dexamethasone With or Without Ixazomib in Treating Patients With Relapsed Multiple Myeloma
Status: Enrolling, Phase I, II
Updated: 12/31/1969
Heartland Hematology Oncology Associates, Incorporated
mi
from
Kansas City, MO
Click here to add this to my saved trials
Multiple Myeloma in Relapse Clinical Trial
Pomalidomide and Dexamethasone With or Without Ixazomib in Treating Patients With Relapsed Multiple Myeloma
Status: Enrolling, Phase I, II
Updated: 12/31/1969
Kadlec Clinic Hematology and Oncology
mi
from
Kennewick, WA
Click here to add this to my saved trials
Multiple Myeloma in Relapse Clinical Trial
Pomalidomide and Dexamethasone With or Without Ixazomib in Treating Patients With Relapsed Multiple Myeloma
Status: Enrolling, Phase I, II
Updated: 12/31/1969
Lawrence Memorial Hospital
mi
from
Lawrence, KS
Click here to add this to my saved trials
Multiple Myeloma in Relapse Clinical Trial
Pomalidomide and Dexamethasone With or Without Ixazomib in Treating Patients With Relapsed Multiple Myeloma
Status: Enrolling, Phase I, II
Updated: 12/31/1969
Minimally Invasive Surgery Hospital
mi
from
Lenexa, KS
Click here to add this to my saved trials
Multiple Myeloma in Relapse Clinical Trial
Pomalidomide and Dexamethasone With or Without Ixazomib in Treating Patients With Relapsed Multiple Myeloma
Status: Enrolling, Phase I, II
Updated: 12/31/1969
Saint Mary Mercy Hospital
mi
from
Livonia, MI
Click here to add this to my saved trials
Multiple Myeloma in Relapse Clinical Trial
Pomalidomide and Dexamethasone With or Without Ixazomib in Treating Patients With Relapsed Multiple Myeloma
Status: Enrolling, Phase I, II
Updated: 12/31/1969
Cancer Center of Kansas-Manhattan
mi
from
Manhattan, KS
Click here to add this to my saved trials
Multiple Myeloma in Relapse Clinical Trial
Pomalidomide and Dexamethasone With or Without Ixazomib in Treating Patients With Relapsed Multiple Myeloma
Status: Enrolling, Phase I, II
Updated: 12/31/1969
Saint Luke's Mountain States Tumor Institute - Meridian
mi
from
Meridian, ID
Click here to add this to my saved trials
Multiple Myeloma in Relapse Clinical Trial
Pomalidomide and Dexamethasone With or Without Ixazomib in Treating Patients With Relapsed Multiple Myeloma
Status: Enrolling, Phase I, II
Updated: 12/31/1969
West Virginia University Healthcare
mi
from
Morgantown, WV
Click here to add this to my saved trials
Multiple Myeloma in Relapse Clinical Trial
Pomalidomide and Dexamethasone With or Without Ixazomib in Treating Patients With Relapsed Multiple Myeloma
Status: Enrolling, Phase I, II
Updated: 12/31/1969
Mercy Health Mercy Campus
mi
from
Muskegon, MI
Click here to add this to my saved trials
Multiple Myeloma in Relapse Clinical Trial
Pomalidomide and Dexamethasone With or Without Ixazomib in Treating Patients With Relapsed Multiple Myeloma
Status: Enrolling, Phase I, II
Updated: 12/31/1969
University of Oklahoma Health Sciences Center
mi
from
Oklahoma City, OK
Click here to add this to my saved trials
Multiple Myeloma in Relapse Clinical Trial
Pomalidomide and Dexamethasone With or Without Ixazomib in Treating Patients With Relapsed Multiple Myeloma
Status: Enrolling, Phase I, II
Updated: 12/31/1969
Saint Charles Hospital
mi
from
Oregon, OH
Click here to add this to my saved trials
Multiple Myeloma in Relapse Clinical Trial
Pomalidomide and Dexamethasone With or Without Ixazomib in Treating Patients With Relapsed Multiple Myeloma
Status: Enrolling, Phase I, II
Updated: 12/31/1969
Radiation Oncology of Northern Illinois
mi
from
Ottawa, IL
Click here to add this to my saved trials
Multiple Myeloma in Relapse Clinical Trial
Pomalidomide and Dexamethasone With or Without Ixazomib in Treating Patients With Relapsed Multiple Myeloma
Status: Enrolling, Phase I, II
Updated: 12/31/1969
Saint Luke's South Hospital
mi
from
Overland Park, KS
Click here to add this to my saved trials
Multiple Myeloma in Relapse Clinical Trial
Pomalidomide and Dexamethasone With or Without Ixazomib in Treating Patients With Relapsed Multiple Myeloma
Status: Enrolling, Phase I, II
Updated: 12/31/1969
Beebe Health Campus
mi
from
Rehoboth Beach, DE
Click here to add this to my saved trials
Multiple Myeloma in Relapse Clinical Trial
Pomalidomide and Dexamethasone With or Without Ixazomib in Treating Patients With Relapsed Multiple Myeloma
Status: Enrolling, Phase I, II
Updated: 12/31/1969
Sainte Genevieve County Memorial Hospital
mi
from
Sainte Genevieve, MO
Click here to add this to my saved trials
Multiple Myeloma in Relapse Clinical Trial
Pomalidomide and Dexamethasone With or Without Ixazomib in Treating Patients With Relapsed Multiple Myeloma
Status: Enrolling, Phase I, II
Updated: 12/31/1969
Memorial Health University Medical Center
mi
from
Savannah, GA
Click here to add this to my saved trials
Multiple Myeloma in Relapse Clinical Trial
Pomalidomide and Dexamethasone With or Without Ixazomib in Treating Patients With Relapsed Multiple Myeloma
Status: Enrolling, Phase I, II
Updated: 12/31/1969
Providence Regional Cancer System-Shelton
mi
from
Shelton, WA
Click here to add this to my saved trials
Multiple Myeloma in Relapse Clinical Trial
Pomalidomide and Dexamethasone With or Without Ixazomib in Treating Patients With Relapsed Multiple Myeloma
Status: Enrolling, Phase I, II
Updated: 12/31/1969
Rockwood Cancer Treatment Center-DHEC-Downtown
mi
from
Spokane, WA
Click here to add this to my saved trials
Multiple Myeloma in Relapse Clinical Trial
Pomalidomide and Dexamethasone With or Without Ixazomib in Treating Patients With Relapsed Multiple Myeloma
Status: Enrolling, Phase I, II
Updated: 12/31/1969
Evergreen Hematology and Oncology, PS
mi
from
Spokane, WA
Click here to add this to my saved trials
Multiple Myeloma in Relapse Clinical Trial
Pomalidomide and Dexamethasone With or Without Ixazomib in Treating Patients With Relapsed Multiple Myeloma
Status: Enrolling, Phase I, II
Updated: 12/31/1969
Mercy Saint Anne Hospital
mi
from
Toledo, OH
Click here to add this to my saved trials
Multiple Myeloma in Relapse Clinical Trial
Pomalidomide and Dexamethasone With or Without Ixazomib in Treating Patients With Relapsed Multiple Myeloma
Status: Enrolling, Phase I, II
Updated: 12/31/1969
MedStar Georgetown University Hospital
mi
from
Washington DC,
Click here to add this to my saved trials
Multiple Myeloma in Relapse Clinical Trial
Pomalidomide and Dexamethasone With or Without Ixazomib in Treating Patients With Relapsed Multiple Myeloma
Status: Enrolling, Phase I, II
Updated: 12/31/1969
Mount Carmel St. Ann's
mi
from
Westerville, OH
Click here to add this to my saved trials
Type II Diabetes Clinical Trial
Januvia (Sitagliptin) in Healing Chronic Diabetic Foot Ulcers
Status: Enrolling, Phase IV
Updated: 10/17/2014
MedStar Georgetown University Hospital
mi
from
Washington DC,
Click here to add this to my saved trials
Oncology Clinical Trial
Immunotherapy Study for Patients With Stage IV Melanoma
Status: Enrolling, Phase II
Updated: 10/28/2015
University of Tennessee Medical Center
mi
from
Knoxville, TN
Click here to add this to my saved trials
Oncology Clinical Trial
Immunotherapy Study for Patients With Stage IV Melanoma
Status: Enrolling, Phase II
Updated: 10/28/2015
Oncology Specialists
mi
from
Niles, IL
Click here to add this to my saved trials
Anemia Clinical Trial
Study to Evaluate the Safety and Efficacy of GSK1278863 in Recombinant Human Erythropoietin (rhEPO) Hyporesponsive Hemodialysis-dependent Chronic Kidney Disease Subjects With Anemia
Status: Enrolling, Phase II
Updated: 3/31/2016
GSK Investigational Site
mi
from
Azusa, CA
Click here to add this to my saved trials
Anemia Clinical Trial
Study to Evaluate the Safety and Efficacy of GSK1278863 in Recombinant Human Erythropoietin (rhEPO) Hyporesponsive Hemodialysis-dependent Chronic Kidney Disease Subjects With Anemia
Status: Enrolling, Phase II
Updated: 3/31/2016
GSK Investigational Site
mi
from
Hollywood, FL
Click here to add this to my saved trials
Anemia Clinical Trial
Study to Evaluate the Safety and Efficacy of GSK1278863 in Recombinant Human Erythropoietin (rhEPO) Hyporesponsive Hemodialysis-dependent Chronic Kidney Disease Subjects With Anemia
Status: Enrolling, Phase II
Updated: 3/31/2016
GSK Investigational Site
mi
from
Paramount, CA
Click here to add this to my saved trials
Anemia Clinical Trial
Study to Evaluate the Safety and Efficacy of GSK1278863 in Recombinant Human Erythropoietin (rhEPO) Hyporesponsive Hemodialysis-dependent Chronic Kidney Disease Subjects With Anemia
Status: Enrolling, Phase II
Updated: 3/31/2016
GSK Investigational Site
mi
from
Simi Valley, CA
Click here to add this to my saved trials
Anemia Clinical Trial
Study to Evaluate the Safety and Efficacy of GSK1278863 in Recombinant Human Erythropoietin (rhEPO) Hyporesponsive Hemodialysis-dependent Chronic Kidney Disease Subjects With Anemia
Status: Enrolling, Phase II
Updated: 3/31/2016
GSK Investigational Site
mi
from
Southgate, MI
Click here to add this to my saved trials
Anemia Clinical Trial
Study to Evaluate the Safety and Efficacy of GSK1278863 in Recombinant Human Erythropoietin (rhEPO) Hyporesponsive Hemodialysis-dependent Chronic Kidney Disease Subjects With Anemia
Status: Enrolling, Phase II
Updated: 3/31/2016
GSK Investigational Site
mi
from
St. Louis, MO
Click here to add this to my saved trials
Metastatic Pancreatic Cancer Clinical Trial
BrUOG 292: FOLFOX-A For Metastatic Pancreatic Cancer: A Phase II Brown University Oncology Research Group Trial
Status: Enrolling, Phase II
Updated: 12/31/1969
Lifespan Hospitals (The Miriam and RI Hospital, East Greenwich, Newport)
mi
from
Providence, RI
Click here to add this to my saved trials
Diabetic Foot Ulcers Clinical Trial
A Comparative Efficacy Study of DermaPure™ to Treat Diabetic Foot Ulcers
Status: Enrolling, Phase IV
Updated: 11/4/2015
Futuro Clinical Trials, LLC
mi
from
McAllen, TX
Click here to add this to my saved trials
HIV Infection Clinical Trial
Elite Controller and ART-treated HIV+ Statin Versus ASA Treatment Intervention Study
Status: Enrolling, Phase II
Updated: 12/31/1969
National Institutes of Health Clinical Center, 9000 Rockville Pike
mi
from
Bethesda, MD
Click here to add this to my saved trials
HIV Infection Clinical Trial
Elite Controller and ART-treated HIV+ Statin Versus ASA Treatment Intervention Study
Status: Enrolling, Phase II
Updated: 12/31/1969
Hennipen County Medical Center
mi
from
Minneapolis, MN
Click here to add this to my saved trials
Carcinoma, Hepatocellular Clinical Trial
Safety and Efficacy of Everolimus Treatment in Liver Transplantation for Liver Cancer
Status: Enrolling, Phase IV
Updated: 12/31/1969
Northwestern University School of Medicine
mi
from
Chicago, IL
Click here to add this to my saved trials
Carcinoma, Hepatocellular Clinical Trial
Safety and Efficacy of Everolimus Treatment in Liver Transplantation for Liver Cancer
Status: Enrolling, Phase IV
Updated: 12/31/1969
Washington University School of Medicine
mi
from
Saint Louis, MO
Click here to add this to my saved trials
Genetics of Drug Metabolism Clinical Trial
Utility of PharmacoGenomics for Reducing Adverse Drug Effects
Status: Enrolling
Updated: 10/7/2015
St. Francis Sleep Allergy & Lung Institute
mi
from
Clearwater, FL
Click here to add this to my saved trials
Genetics of Drug Metabolism Clinical Trial
Utility of PharmacoGenomics for Reducing Adverse Drug Effects
Status: Enrolling
Updated: 10/7/2015
John Allen, M.D.
mi
from
El Cajon, CA
Click here to add this to my saved trials
Genetics of Drug Metabolism Clinical Trial
Utility of PharmacoGenomics for Reducing Adverse Drug Effects
Status: Enrolling
Updated: 10/7/2015
First Coast Cardiovascular Institute
mi
from
Jacksonville, FL
Click here to add this to my saved trials
Genetics of Drug Metabolism Clinical Trial
Utility of PharmacoGenomics for Reducing Adverse Drug Effects
Status: Enrolling
Updated: 10/7/2015
Guthrie Foundation for Education and Research
mi
from
Sayre, PA
Click here to add this to my saved trials
Genetics of Drug Metabolism Clinical Trial
Utility of PharmacoGenomics for Reducing Adverse Drug Effects
Status: Enrolling
Updated: 10/7/2015
Family Medicine and Occupational Health, Inc
mi
from
Shaker Heights, OH
Click here to add this to my saved trials
Genetics of Drug Metabolism Clinical Trial
Utility of PharmacoGenomics for Reducing Adverse Drug Effects
Status: Enrolling
Updated: 10/7/2015
Abington Neurological Associates
mi
from
Willow Grove, PA
Click here to add this to my saved trials
Granulomatous Disease, Chronic Clinical Trial
Patients Treated for Chronic Granulomatous Disease (CGD) Since 1995
Status: Enrolling, Phase
Updated: 12/31/1969
Cincinnati Children's Hospital Medical Center
mi
from
Cincinnati, OH
Click here to add this to my saved trials
Granulomatous Disease, Chronic Clinical Trial
Patients Treated for Chronic Granulomatous Disease (CGD) Since 1995
Status: Enrolling, Phase
Updated: 12/31/1969
Oregon Health and Science University
mi
from
Portland, OR
Click here to add this to my saved trials
Granulomatous Disease, Chronic Clinical Trial
Patients Treated for Chronic Granulomatous Disease (CGD) Since 1995
Status: Enrolling, Phase
Updated: 12/31/1969
Ann & Robert H. Lurie Children's Hospital of Chicago
mi
from
Chicago, IL
Click here to add this to my saved trials
Granulomatous Disease, Chronic Clinical Trial
Patients Treated for Chronic Granulomatous Disease (CGD) Since 1995
Status: Enrolling, Phase
Updated: 12/31/1969
Hackensack University Medical Center
mi
from
Hackensack, NJ
Click here to add this to my saved trials
Granulomatous Disease, Chronic Clinical Trial
Patients Treated for Chronic Granulomatous Disease (CGD) Since 1995
Status: Enrolling, Phase
Updated: 12/31/1969
Phoenix Children's Hospital
mi
from
Phoenix, AZ
Click here to add this to my saved trials
Granulomatous Disease, Chronic Clinical Trial
Patients Treated for Chronic Granulomatous Disease (CGD) Since 1995
Status: Enrolling, Phase
Updated: 12/31/1969
Methodist Children's Hospital of South Texas/Texas Transplant Institute
mi
from
San Antonio, TX
Click here to add this to my saved trials
Cardiology / Vascular Diseases, Other Clinical Trial
Long QT and Hearing Loss Registry
Status: Enrolling
Updated: 1/31/2018
Alexandria Hospital- Inova Health System
mi
from
Alexandria, VA
Click here to add this to my saved trials
Cardiology / Vascular Diseases, Other Clinical Trial
Long QT and Hearing Loss Registry
Status: Enrolling
Updated: 1/31/2018
Osceola Regional Med Ctr
mi
from
Kissimmee, FL
Click here to add this to my saved trials
Cardiology / Vascular Diseases, Other Clinical Trial
Long QT and Hearing Loss Registry
Status: Enrolling
Updated: 1/31/2018
Lexington Medical Center
mi
from
West Columbia, SC
Click here to add this to my saved trials
Scoliosis Clinical Trial
Robotic vs. Freehand Corrective Surgery for Pediatric Scoliosis
Status: Enrolling, Phase
Updated: 12/31/1969
Children's Healtchare of Atlanta at Scottish Rite
mi
from
Atlanta, GA
Click here to add this to my saved trials
Scoliosis Clinical Trial
Robotic vs. Freehand Corrective Surgery for Pediatric Scoliosis
Status: Enrolling, Phase
Updated: 12/31/1969
Florida Hospital for Children
mi
from
Orlando, FL
Click here to add this to my saved trials
Oncology Clinical Trial
Image-guided Cryoablation of Head, Neck and Spine Tumors
Status: Enrolling
Updated: 3/5/2018
Brigham and Women's Hosp
mi
from
Boston, MA
Click here to add this to my saved trials
Hematology, Oncology Clinical Trial
A Phase II Study of Doxycycline in Relapsed NHL
Status: Enrolling, Phase II
Updated: 7/23/2015
University of Rochester
mi
from
Rochester, NY
Click here to add this to my saved trials
Endocrinology Clinical Trial
BMI Screening and Reporting in Schools: The Fit Study
Status: Enrolling
Updated: 12/1/2014
UC Berkeley School of Public Health
mi
from
Berkeley, CA
Click here to add this to my saved trials
Aortic Stenosis Clinical Trial
PERIGON Pivotal Trial
Status: Enrolling, Phase III
Updated: 12/31/1969
Cleveland Clinic
mi
from
Cleveland, OH
Click here to add this to my saved trials
Aortic Stenosis Clinical Trial
PERIGON Pivotal Trial
Status: Enrolling, Phase III
Updated: 12/31/1969
University of Colorado Hospital
mi
from
Aurora, CO
Click here to add this to my saved trials
Aortic Stenosis Clinical Trial
PERIGON Pivotal Trial
Status: Enrolling, Phase III
Updated: 12/31/1969
Houston Methodist Hospital
mi
from
Houston, TX
Click here to add this to my saved trials
Aortic Stenosis Clinical Trial
PERIGON Pivotal Trial
Status: Enrolling, Phase III
Updated: 12/31/1969
University of Southern California (USC) University Hospital
mi
from
Los Angeles, CA
Click here to add this to my saved trials
1 … 46 47 48 49 50 51 52 53 54 55 56 57 58 59 60 61 62 … 1,845